nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Dry skin—Prednisolone—ankylosing spondylitis	0.0145	0.0145	CcSEcCtD
Midodrine—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.014	0.014	CcSEcCtD
Midodrine—Irritability—Methylprednisolone—ankylosing spondylitis	0.0139	0.0139	CcSEcCtD
Midodrine—Irritability—Betamethasone—ankylosing spondylitis	0.0126	0.0126	CcSEcCtD
Midodrine—Irritability—Dexamethasone—ankylosing spondylitis	0.0126	0.0126	CcSEcCtD
Midodrine—Dry skin—Betamethasone—ankylosing spondylitis	0.0121	0.0121	CcSEcCtD
Midodrine—Dry skin—Dexamethasone—ankylosing spondylitis	0.0121	0.0121	CcSEcCtD
Midodrine—Bradycardia—Prednisolone—ankylosing spondylitis	0.0112	0.0112	CcSEcCtD
Midodrine—Irritability—Prednisone—ankylosing spondylitis	0.011	0.011	CcSEcCtD
Midodrine—Dry skin—Prednisone—ankylosing spondylitis	0.0106	0.0106	CcSEcCtD
Midodrine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.0103	0.0103	CcSEcCtD
Midodrine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.0103	0.0103	CcSEcCtD
Midodrine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00935	0.00935	CcSEcCtD
Midodrine—Bradycardia—Betamethasone—ankylosing spondylitis	0.00933	0.00933	CcSEcCtD
Midodrine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00933	0.00933	CcSEcCtD
Midodrine—Irritability—Methotrexate—ankylosing spondylitis	0.0092	0.0092	CcSEcCtD
Midodrine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00914	0.00914	CcSEcCtD
Midodrine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00883	0.00883	CcSEcCtD
Midodrine—Back pain—Triamcinolone—ankylosing spondylitis	0.0085	0.0085	CcSEcCtD
Midodrine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00831	0.00831	CcSEcCtD
Midodrine—Angiopathy—Betamethasone—ankylosing spondylitis	0.00831	0.00831	CcSEcCtD
Midodrine—Hypertension—Prednisolone—ankylosing spondylitis	0.00825	0.00825	CcSEcCtD
Midodrine—Bradycardia—Prednisone—ankylosing spondylitis	0.00812	0.00812	CcSEcCtD
Midodrine—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00799	0.00799	CcSEcCtD
Midodrine—Dysuria—Methotrexate—ankylosing spondylitis	0.00779	0.00779	CcSEcCtD
Midodrine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00761	0.00761	CcSEcCtD
Midodrine—Hypertension—Triamcinolone—ankylosing spondylitis	0.00759	0.00759	CcSEcCtD
Midodrine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00757	0.00757	CcSEcCtD
Midodrine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00744	0.00744	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00742	0.00742	CcSEcCtD
Midodrine—Flushing—Prednisone—ankylosing spondylitis	0.00741	0.00741	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00736	0.00736	CcSEcCtD
Midodrine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00732	0.00732	CcSEcCtD
Midodrine—Stomatitis—Methotrexate—ankylosing spondylitis	0.00724	0.00724	CcSEcCtD
Midodrine—Angiopathy—Prednisone—ankylosing spondylitis	0.00724	0.00724	CcSEcCtD
Midodrine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00722	0.00722	CcSEcCtD
Midodrine—Insomnia—Prednisolone—ankylosing spondylitis	0.00706	0.00706	CcSEcCtD
Midodrine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00703	0.00703	CcSEcCtD
Midodrine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00702	0.00702	CcSEcCtD
Midodrine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.007	0.007	CcSEcCtD
Midodrine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.007	0.007	CcSEcCtD
Midodrine—Mental disorder—Prednisone—ankylosing spondylitis	0.00699	0.00699	CcSEcCtD
Midodrine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00699	0.00699	CcSEcCtD
Midodrine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00695	0.00695	CcSEcCtD
Midodrine—Hypertension—Dexamethasone—ankylosing spondylitis	0.00689	0.00689	CcSEcCtD
Midodrine—Hypertension—Betamethasone—ankylosing spondylitis	0.00689	0.00689	CcSEcCtD
Midodrine—Anxiety—Betamethasone—ankylosing spondylitis	0.00677	0.00677	CcSEcCtD
Midodrine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00677	0.00677	CcSEcCtD
Midodrine—Pain—Prednisolone—ankylosing spondylitis	0.00667	0.00667	CcSEcCtD
Midodrine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00659	0.00659	CcSEcCtD
Midodrine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00654	0.00654	CcSEcCtD
Midodrine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00649	0.00649	CcSEcCtD
Midodrine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00647	0.00647	CcSEcCtD
Midodrine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00644	0.00644	CcSEcCtD
Midodrine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00643	0.00643	CcSEcCtD
Midodrine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00643	0.00643	CcSEcCtD
Midodrine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.0064	0.0064	CcSEcCtD
Midodrine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00638	0.00638	CcSEcCtD
Midodrine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00638	0.00638	CcSEcCtD
Midodrine—Agitation—Prednisone—ankylosing spondylitis	0.00638	0.00638	CcSEcCtD
Midodrine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00635	0.00635	CcSEcCtD
Midodrine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00635	0.00635	CcSEcCtD
Midodrine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00631	0.00631	CcSEcCtD
Midodrine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.0063	0.0063	CcSEcCtD
Midodrine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.0063	0.0063	CcSEcCtD
Midodrine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00619	0.00619	CcSEcCtD
Midodrine—Pain—Triamcinolone—ankylosing spondylitis	0.00613	0.00613	CcSEcCtD
Midodrine—Angiopathy—Methotrexate—ankylosing spondylitis	0.00605	0.00605	CcSEcCtD
Midodrine—Hypertension—Prednisone—ankylosing spondylitis	0.006	0.006	CcSEcCtD
Midodrine—Chills—Methotrexate—ankylosing spondylitis	0.00598	0.00598	CcSEcCtD
Midodrine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00591	0.00591	CcSEcCtD
Midodrine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Midodrine—Anxiety—Prednisone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Midodrine—Insomnia—Betamethasone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Midodrine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00587	0.00587	CcSEcCtD
Midodrine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00585	0.00585	CcSEcCtD
Midodrine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00584	0.00584	CcSEcCtD
Midodrine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00584	0.00584	CcSEcCtD
Midodrine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00584	0.00584	CcSEcCtD
Midodrine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00573	0.00573	CcSEcCtD
Midodrine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00573	0.00573	CcSEcCtD
Midodrine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00566	0.00566	CcSEcCtD
Midodrine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00562	0.00562	CcSEcCtD
Midodrine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00562	0.00562	CcSEcCtD
Midodrine—Back pain—Methotrexate—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Midodrine—Pain—Betamethasone—ankylosing spondylitis	0.00557	0.00557	CcSEcCtD
Midodrine—Pain—Dexamethasone—ankylosing spondylitis	0.00557	0.00557	CcSEcCtD
Midodrine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00556	0.00556	CcSEcCtD
Midodrine—Tachycardia—Prednisone—ankylosing spondylitis	0.00553	0.00553	CcSEcCtD
Midodrine—Skin disorder—Prednisone—ankylosing spondylitis	0.00551	0.00551	CcSEcCtD
Midodrine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00536	0.00536	CcSEcCtD
Midodrine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00536	0.00536	CcSEcCtD
Midodrine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00532	0.00532	CcSEcCtD
Midodrine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00532	0.00532	CcSEcCtD
Midodrine—Dizziness—Prednisolone—ankylosing spondylitis	0.00516	0.00516	CcSEcCtD
Midodrine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00515	0.00515	CcSEcCtD
Midodrine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00515	0.00515	CcSEcCtD
Midodrine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00515	0.00515	CcSEcCtD
Midodrine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Midodrine—Insomnia—Prednisone—ankylosing spondylitis	0.00513	0.00513	CcSEcCtD
Midodrine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00509	0.00509	CcSEcCtD
Midodrine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00508	0.00508	CcSEcCtD
Midodrine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00506	0.00506	CcSEcCtD
Midodrine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00499	0.00499	CcSEcCtD
Midodrine—Rash—Prednisolone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Midodrine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Midodrine—Headache—Prednisolone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Midodrine—Confusional state—Methotrexate—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Midodrine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00474	0.00474	CcSEcCtD
Midodrine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00473	0.00473	CcSEcCtD
Midodrine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00467	0.00467	CcSEcCtD
Midodrine—Asthenia—Betamethasone—ankylosing spondylitis	0.00467	0.00467	CcSEcCtD
Midodrine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00467	0.00467	CcSEcCtD
Midodrine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Midodrine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00464	0.00464	CcSEcCtD
Midodrine—Nausea—Prednisolone—ankylosing spondylitis	0.00463	0.00463	CcSEcCtD
Midodrine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00461	0.00461	CcSEcCtD
Midodrine—Pruritus—Betamethasone—ankylosing spondylitis	0.00461	0.00461	CcSEcCtD
Midodrine—Skin disorder—Methotrexate—ankylosing spondylitis	0.0046	0.0046	CcSEcCtD
Midodrine—Rash—Triamcinolone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Midodrine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Midodrine—Rash—Methylprednisolone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Midodrine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Midodrine—Headache—Triamcinolone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Midodrine—Headache—Methylprednisolone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Midodrine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Midodrine—Dizziness—Betamethasone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Midodrine—Dizziness—Dexamethasone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Midodrine—Insomnia—Methotrexate—ankylosing spondylitis	0.00428	0.00428	CcSEcCtD
Midodrine—Nausea—Triamcinolone—ankylosing spondylitis	0.00426	0.00426	CcSEcCtD
Midodrine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Midodrine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Midodrine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Midodrine—Somnolence—Methotrexate—ankylosing spondylitis	0.00421	0.00421	CcSEcCtD
Midodrine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00417	0.00417	CcSEcCtD
Midodrine—Rash—Betamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Midodrine—Rash—Dexamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Midodrine—Dermatitis—Betamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Midodrine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Midodrine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Midodrine—Headache—Betamethasone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Midodrine—Headache—Dexamethasone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Midodrine—Asthenia—Prednisone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Midodrine—Pain—Methotrexate—ankylosing spondylitis	0.00405	0.00405	CcSEcCtD
Midodrine—Pruritus—Prednisone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Midodrine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Midodrine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Midodrine—Nausea—Dexamethasone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Midodrine—Nausea—Betamethasone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Midodrine—Dizziness—Prednisone—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Midodrine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Midodrine—Rash—Prednisone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Midodrine—Dermatitis—Prednisone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Midodrine—Headache—Prednisone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Midodrine—Asthenia—Methotrexate—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Midodrine—Nausea—Prednisone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Midodrine—Pruritus—Methotrexate—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Midodrine—Dizziness—Methotrexate—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Midodrine—Rash—Methotrexate—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Midodrine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Midodrine—Headache—Methotrexate—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Midodrine—Nausea—Methotrexate—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
